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Available online 3 June 2016Background: Structural brain abnormalities in schizophrenia have been repeatedly demonstrated in magnetic
resonance imaging (MRI) studies, but it remains unclear whether these are static or progressive in nature.
While longitudinalMRI studies have been traditionally used to assess the issue of progression of brain abnormal-
ities in schizophrenia, information from cross-sectional neuroimaging studies directly comparing ﬁrst-episode
and chronic schizophrenia patients to healthy controls may also be useful to further clarify this issue. With the
recent interest in multisite mega-analyses combining structural MRI data from multiple centers aiming at in-
creased statistical power, the presentmultisite voxel-basedmorphometry (VBM) studywas carried out to exam-
ine patterns of brain structural changes according to the different stages of illness and to ascertain which (if any)
of such structural abnormalities would be speciﬁcally correlated to potential clinical moderators, including cu-
mulative exposure to antipsychotics, age of onset, illness duration and overall illness severity.
Methods:We gathered a large sample of schizophrenia patients (161, being 99 chronic and 62 ﬁrst-episode) and
controls (151) from four previous morphometric MRI studies (1.5 T) carried out in the same geographical region
of Brazil. Image processing and analyses were conducted using Statistical Parametric Mapping (SPM8) software
with the diffeomorphic anatomical registration through exponentiated Lie algebra (DARTEL) algorithm. Group
effects on regional gray matter (GM) volumes were investigated through whole-brain voxel-wise comparisons
using General LinearModel Analysis of Co-variance (ANCOVA), always including total GM volume, scan protocol,
age and gender as nuisance variables. Finally, correlation analyses were performed between the aforementioned
clinical moderators and regional and global brain volumes.
Results: First-episode schizophrenia subjects displayed subtle volumetric deﬁcits relative to controls in a
circumscribed brain regional network identiﬁed only in small volume-corrected (SVC) analyses (p b 0.05,
FWE-corrected), including the insula, temporolimbic structures and striatum. Chronic schizophrenia patients,
on the other hand, demonstrated an extensive pattern of regional GM volume decreases relative to controls, in-
volving bilateral superior, inferior and orbital frontal cortices, rightmiddle frontal cortex, bilateral anterior cingu-
late cortices, bilateral insulae and right superior and middle temporal cortices (p b 0.05, FWE-corrected over the
whole brain). GM volumes in several of those brain regions were directly correlated with age of disease onset on
SVC analyses for conjoined (ﬁrst-episode and chronic) schizophrenia groups. There were also widespread foci of
signiﬁcant negative correlation between duration of illness and relative GMvolumes, but such ﬁndings remainedKeywords:
Voxel-based morphometry
MRI
Schizophreniain Psychiatry (LIM-21), Institute of Psychiatry, University of Sao PauloMedical School, Centro deMedicinaNuclear, 3° andar, Rua
ulo, Brazil.
. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
2 U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15signiﬁcant only for the right dorsolateral prefrontal cortex after accounting for the inﬂuence of age of disease
onset. Finally, signiﬁcant negative correlationswere detected between life-time cumulative exposure to antipsy-
chotics and total GM and white matter volumes in schizophrenia patients, but no signiﬁcant relationship was
found between indices of antipsychotic usage and relative GM volume in any speciﬁc brain region.
Conclusion: The above data indicate that brain changes associated with the diagnosis of schizophrenia are more
widespread in chronic schizophrenia compared to ﬁrst-episode patients. Our ﬁndings also suggest that relative
GMvolumedeﬁcitsmay be greater in (presumablymore severe) caseswith earlier age of onset, aswell as varying
as a function of illness duration in speciﬁc frontal brain regions. Finally, our results highlight the potentially com-
plex effects of the continued use of antipsychotic drugs on structural brain abnormalities in schizophrenia, as we
found that cumulative doses of antipsychotics affected brain volumes globally rather than selectively on frontal-
temporal regions.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Structural brain abnormalities have been repeatedly demonstrated
in groups of patients with schizophrenia compared to healthy controls
inmagnetic resonance imaging (MRI) studies, with some of the ﬁndings
being observed at (or even before) the onset of illness (Steen et al.,
2006; Vita et al., 2012; Ellison-Wright et al., 2008; Shenton et al.,
2001; Fusar-Poli et al., 2011; Smieskova et al., 2010). However, it is
not clearwhether such structural brain changes are static or progressive
in nature (Vita et al., 2012; van Haren et al., 2008; DeLisi, 2008;
Weinberger & McClure, 2002; Chan et al., 2011; Zipursky et al., 2013;
Olabi et al., 2011).
Although longitudinal MRI studies have been traditionally used to
address the question of progression of brain abnormalities in schizo-
phrenia, information from cross-sectional neuroimaging studies may
also provide useful contributions to further clarify this issue (Pantelis
et al., 2005). Cross-sectional MRI comparisons of patients with ﬁrst-ep-
isode and chronic schizophrenia are of interest because if there aremore
widespread brain changes in chronic than in ﬁrst-episode psychosis,
then this could imply a progression of brain anatomical changes after
symptom onset (Ellison-Wright et al., 2008). Moreover, if structural
brain changes are less widespread in ﬁrst-episode schizophrenia, then
the foci of such abnormalities could be seen as the critical brain regions
of neuropathology from which continuing abnormalities may evolve to
further, more widespread anatomical changes in chronic schizophrenia
(Ellison-Wright et al., 2008). However, such cross-sectional approach
has hitherto been applied primarily in meta-analytic investigations
that indirectly compared groups of MRI studies on ﬁrst-episode versus
groups of studies on chronic schizophrenia (Vita et al., 2012;
Ellison-Wright et al., 2008; Chan et al., 2011; Olabi et al., 2011; Honea
et al., 2005). Conversely, original cross-sectional MRI studies directly
comparing ﬁrst-episode and chronic schizophrenia patients to controls
selected from the same geographical area have been very scarce to date
(Meisenzahl et al., 2008). Not infrequently, cross-sectional MRI studies
actually pool together both chronic and ﬁrst-episode patients (Meda
et al., 2008; Antonova et al., 2005; Honea et al., 2008), do not explicitly
report the duration of illness (Garcia-Marti et al., 2008; Moorhead et al.,
2004; Tregellas et al., 2007), or even do not apply strict criteria to deﬁne
these patient groups in regard to the stage of illness (Keshavan &
Schooler, 1992).
Recently, there has been growing interest in multisite mega-analy-
ses combining structural MRI data frommultiple centers through a uni-
form procedure of preprocessing and analysis, aiming at increased
sensitivity and statistical power to detect group differences and investi-
gate within-group correlations with clinical variables (de Wit et al.,
2014; Gupta et al., 2014; Jednorog et al., 2015; Mueller et al., 2005;
Segall et al., 2009; Turner et al., 2012). Three of thesemultisiteMRI stud-
ies have evaluated subjects with schizophrenia applying the voxel-
based morphometry (VBM) approach (Gupta et al., 2014; Segall et al.,
2009; Turner et al., 2012), whereby differences in graymatter (GM) vol-
umes between schizophrenia patients and controls were investigatedon a voxel-by-voxel basis across the entire brain. Also, the increased sta-
tistical power arising from VBM studies with large samples may help to
disentangle to what extent progression of brain changes may be a con-
sequence of an ongoing pathophysiological process in schizophrenia or
a result of potential clinicalmoderators such as antipsychotics usage, for
example. This is relevant since recent studies have suggested that anti-
psychotics, the cornerstone of the treatment of schizophrenia, may be
signiﬁcantly associated to some of the progressive neuroanatomical
changes previously reported in some MRI studies of schizophrenia,
even after accounting for other potentialmoderators such as disease du-
ration, illness severity and substance abuse (Ho et al., 2011; Fusar-Poli
et al., 2013; Torres et al., 2013). Moreover, VBM studies using large
schizophrenia and control samples may also afford statistical power to
evaluate the potential inﬂuence of other clinical moderators on GM vol-
umes, such as duration of illness and the overall severity of schizophre-
nia clinical features.
In the present cross-sectional, multisite VBM study, we sought to
replicate ﬁndings of brain structural changes in schizophrenia reported
in previous large-sized VBM investigations (Vita et al., 2012;
Ellison-Wright et al., 2008; Chan et al., 2011; Olabi et al., 2011; Honea
et al., 2005) by comparing groups of ﬁrst-episode and chronic patients
relative to demographically matched controls, all recruited in the state
of São Paulo, Brazil. We hypothesized that chronic schizophrenia pa-
tients would have a more spatially widespread pattern of brain volume
abnormalities than ﬁrst-episode schizophrenia patients. Also, we aimed
to ascertain which (if any) of such structural brain changes would be
speciﬁcally correlated to potential clinical moderators including cumu-
lative exposure to antipsychotics, age of onset, illness duration and
overall illness severity.
2. Methods
2.1. Subjects
The present investigation gathered a large sample of schizophrenia
patients and controls from four previousmorphometricMRI studies car-
ried out in medical institutions of two cities located in the same geo-
graphical region of Brazil (São Paulo State), namely the University of
São Paulo Medical School in São Paulo City, and the University of São
Paulo Medical School in Ribeirão Preto City. Such MRI studies had
been carried out to address different research questions and their sepa-
rate results have been published elsewhere (Bassitt et al., 2007; Sallet et
al., 2003; Schaufelberger et al., 2007; de Souza Crippa et al., 2006). All
participants provided written informed consent at the time of the orig-
inal MRI studies, and permission for this multisite data analysis was ob-
tained from the ethical review board at University of São Paulo Medical
School. We included a total of 312 non-overlapping subjects, being 161
schizophrenia patients (99 chronic, 62 ﬁrst-episode) and 151 controls
who underwent 1.5 T structural T1-weighted MRI scanning. In studies
of this kind, carried out with the primary aim to dichotomize schizo-
phrenia samples regarding illness duration, great care must be taken
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an duration of disease in comparison to their counterpart, i.e., the ﬁrst-
episode sample. Therefore, when selecting studies for this mega-analy-
sis we adopted a rigid criterion to deﬁne illness chronicity, as applied
elsewhere (Chan et al., 2011): median illness duration could not be
less than 5 years in each study involving chronic schizophrenia patients
(Bassitt et al., 2007; Sallet et al., 2003; de Souza Crippa et al., 2006); sim-
ilarly, the selected ﬁrst-episode schizophrenia subjects (Schaufelberger
et al., 2007) had amedian duration of illness of less than 1 year (Chan et
al., 2011).
Chronic schizophrenia patients were recruited at local outpatient
clinics at the Institute of Psychiatry of University of São Paulo (Bassitt
et al., 2007; Sallet et al., 2003) and the University Hospital of the Faculty
of Medicine of Ribeirão Preto (de Souza Crippa et al., 2006). Differently,
ﬁrst-episode schizophrenia patients (Schaufelberger et al., 2007) were
drawn from a sample of people with ﬁrst-episode psychosis identiﬁed
for an epidemiological study of the incidence of psychotic disorders in
São Paulo (Menezes et al., 2007); people presentingwith a psychotic ill-
ness andwhomade contact for theﬁrst timewith themental healthcare
services for that region (a circumscribed geographical area of São Paulo
comprising a total of approximately 900,000 inhabitants) were recruit-
ed by active surveillance.
Inclusion criteria for schizophrenia subjects were: diagnosis of
schizophrenia according to DSM-IV criteria on the basis of interviews
with the Structured Clinical Interview for DSM-IV Axis I Disorders for
all studies (First et al., 1996); and an age at the time of MRI scanning
ranging between 18 to 50 years in three studies (Bassitt et al., 2007;
Schaufelberger et al., 2007; de Souza Crippa et al., 2006), and 18 to
60 years in the remaining study (Sallet et al., 2003). People with psy-
chotic disorders due to a general medical condition or substance-in-
duced psychosis were excluded.
In three of theMRI studies (Bassitt et al., 2007; Sallet et al., 2003; de
Souza Crippa et al., 2006), healthy controlswere recruited from the local
community through local advertisements or invited by word of mouth,
which in one study also includedmembers from the staff at the Institute
of Psychiatry at the University of São Paulo Medical School in São Paulo
city (Bassitt et al., 2007). For the remaining MRI study (the study on
ﬁrst-episode patients) (Schaufelberger et al., 2007), an epidemiological
approach was applied for the recruitment of controls, randomly
selecting a large group without psychosis from the same geographical
area, comprised by next-door neighbors from ﬁrst-episode patients;
such population-based approachwas used in that study in order tomin-
imize the chance of selection bias (32).
Exclusion criteria speciﬁc for the control group were personal histo-
ry of other Axis I disorders (as determined by interviews using the SCID)
(Bassitt et al., 2007; Sallet et al., 2003; de Souza Crippa et al., 2006) or
psychosis (Bassitt et al., 2007; Sallet et al., 2003; Schaufelberger et al.,
2007; de Souza Crippa et al., 2006). Additional exclusion criteria for
both groups were: history of head injury (Bassitt et al., 2007; Sallet et
al., 2003; Schaufelberger et al., 2007; de Souza Crippa et al., 2006); pres-
ence of neurological disorders or any organic disorders that could affect
the central nervous system (Bassitt et al., 2007; Sallet et al., 2003;
Schaufelberger et al., 2007; de Souza Crippa et al., 2006); previous treat-
ment with steroid medication (Sallet et al., 2003); contraindications for
MRI scanning (Bassitt et al., 2007; Sallet et al., 2003; Schaufelberger et
al., 2007; de Souza Crippa et al., 2006); major medical illnesses (de
Souza Crippa et al., 2006); and substance abuse (Sallet et al., 2003; de
Souza Crippa et al., 2006).
Detailed sociodemographic and clinical data were retrieved from
schizophrenia patients of each site. Althoughdifferent scales for psycho-
pathology severitywere originally published in each study (Bassitt et al.,
2007; Sallet et al., 2003; Schaufelberger et al., 2007; de Souza Crippa et
al., 2006), scores of the Positive and Negative Syndrome Scale (PANSS)
(Kay et al., 1987) were commonly available in most of the databases
(Bassitt et al., 2007; Sallet et al., 2003; Schaufelberger et al., 2007), ex-
cept for one (de Souza Crippa et al., 2006); therefore, for the presentmega-analysis, symptom severity was rated using the PANSS, using
only the three samples that had these data available.
We also collected data on antipsychotics usage (typical or atypical
drugs, duration of exposure, dose at the time of MRI scanning and life-
time cumulative exposure). Given that many schizophrenia patients
are maintained on antipsychotic treatment for long periods, it is useful
to quantitatively assess cumulative medication exposure, especially be-
cause recent studies have highlighted the potential association between
structural brain changes and use of antipsychotics in schizophrenia (Ho
et al., 2011; Torres et al., 2013; Moncrieff & Leo, 2010; Smieskova et al.,
2009; Navari & Dazzan, 2009). In order to calculate lifetime cumulative
antipsychotic exposure, we ﬁrst converted antipsychotic doses to chlor-
promazine (CPZ) milligram equivalent units (Andreasen et al., 2010).
We subsequently calculated, for each patient, total cumulative exposure
expressed in dose-years (Andreasen et al., 2010). In cases of chronic an-
tipsychotics exposure, it is worth mentioning that antipsychotic treat-
ment is naturalistic and patients usually receive a standard treatment
at discretion of treatingpsychiatrist (Ho et al., 2011). Thus, in large,mul-
tisite studies like ours, by using retrospective methods (chart reviews),
available data on antipsychotics may be heterogeneous and somewhat
limited, making it difﬁcult to obtain measurements of lifetime antipsy-
chotic exposure with accuracy (Ho et al., 2011). Therefore, we derived
cumulative antipsychotic exposure using a product of deﬁned daily
dose and duration of illness as determined from patients' charts. This
index can be taken as an approximate measure of lifetime antipsychotic
exposure (Palaniyappan et al., 2014).
2.2. MRI acquisition and image processing
High-resolution T1-weighted images were acquired in four different
sites of the two medical institutions, with imaging parameters as sum-
marized in Table 1. Prior to data processing, all scans successfully passed
a quality assessment protocol, based on visual inspection for gross struc-
tural abnormalities, artifacts, or poor image quality that could potential-
ly hamper image segmentation. Imaging data processing and analysis
were carried out using VBMmethods based on the Statistical Parametric
Mapping 8 software package (SPM8;Wellcome Trust Centre for Neuro-
imaging; http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm8/) run in
MATLAB (Mathworks, USA). Brieﬂy, following manual reorientation in
order to place the anterior commissure at the origin of the three-dimen-
sional Montreal Neurological Institute (MNI) coordinate system, T1-W
images were segmented into tissue classes of GM, white matter
(WM), and cerebrospinal ﬂuid (CSF) by using the standard uniﬁed seg-
mentation model in SPM8 (Ashburner & Friston, 2005), which makes
use of tissue probability maps reﬂecting the prior probability of a
given voxel belonging to any tissue class (Ashburner & Friston, 2005).
The Diffeomorphic Anatomical Registration Through Exponentiated
Lie Algebra (DARTEL) algorithm (Ashburner, 2007) was employed to
create a study-speciﬁc template for spatial normalization of the seg-
mented images of each subject.
The resulting ﬂow ﬁelds created by DARTEL were used to generate
GM andWM images of each individual; such images were spatially nor-
malized in the MNI space, modulated, resliced (1.0-mm isotropic
voxels), and smoothed (8-mm full-width at half maximum Gaussian
kernel). In order to compensate for the effects of spatial normalization,
GM and WM normalized images are modulated by multiplying each
voxel value by its relative volume before and after warping, which al-
lows obtaining relative volume for each voxel; the maps so produced
are referred to as images of GMandWMvolumes in order to distinguish
them from the images of “concentration” or “density” that result if the
modulation stage is omitted (Segall et al., 2009; Sundram et al., 2010).
Therefore, volumes of GM,WMand CSFwere calculated by theMATLAB
get_totals script (http://www.cs.ucl.ac.uk/staff/g.ridgway/vbm/get_
totals.m) implemented for SPM8 on the native space gray, white, and
cerebrospinal ﬂuid segmentations for each subject. Similarly, to com-
pute total intracranial volume (TIV) using SPM's uniﬁed segmentation
Table 1
Scanning Sequences Used in Each Magnetic Resonance Imaging Study.
Study Author (year) N Type of 1.5 T MRI scanner MRI scan sequence parameters
Patients Controls Total Vendor Model Sequence TR
(ms)
TE
(ms)
FA Orientation Thickness
(mm)
Field of
view
Matrix
size
1 Sallet et al. (2003) 35 15 50 Philips Gyroscan
S15-ACS
FFE 30 9 30° Coronal 1.2 240 256 × 256
2 de Souza Crippa et al.
(2006)
20 16 36 Siemens Magneton
Vision
FLASH 9.7 4 12° Sagittal 1.0 256 256 × 256
3 Schaufelberger et al.
(2007)
62 94 156 General
Electric
Signa Horizon SPGR 21.7 5.2 20° Axial 1.5 220 256 × 192
4 Bassitt et al. (2007) 44 26 70 General
Electric
Signa Horizon SPGR 9 1.9 20° Sagittal 1.2 220 256 × 192
TR = repetition time; TE = echo time, FA = ﬂip angle.
4 U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15and spatial normalization procedure, probabilistic tissue class images
can be integrated, with the estimated TIV simply being the sum of
GM, WM and CSF volumes (Ansell et al., 2012; Benedetti et al., 2010;
Malone et al., 2015), as herein adopted. Total brain volume (TBV) was
estimated by summing GM and WM volumes (Nordenskjöld et al.,
2013). However, tissue prior probability templates used in SPM are
based on averaging multiple automatically segmented images in stan-
dard space, with no certainty that the sumof these three compartments
will be exactly consistentwith accepted deﬁnitions of TIV (Malone et al.,
2015). For instance, such automated method of TIV estimation in SPM8
was found to overestimate TIV by 20.86% as compared to manual seg-
mentation (Nordenskjöld et al., 2013), these errors being shown to im-
pact the ability to detect differences in hippocampal volume, for
example (Nordenskjöld et al., 2013). It is expected that improved new
segmentation algorithms incorporated into SPM8 and SPM12 can pro-
duce more accurate TIV results, despite current evidence for this are
yet scarce (Malone et al., 2015).
Finally, in order to ensure that all imageswere segmented adequate-
ly, subject outlier detection was performed within and across the four
sites using a Pearson correlation, by comparing the degree towhich sub-
jects were related to the average smoothed GMmap. Outliers were de-
ﬁned as subjects deviating more than 2% from the mean GM volumes,
according to criteria deﬁned elsewhere (Segall et al., 2009); no outlier
was identiﬁed.
2.3. Statistical analysis
Group differences in demographic characteristics were assessed
with IBM SPSS Statistics, version 21 (IBM, Armonk, USA). The signiﬁ-
cance threshold was set at 0.05, two-tailed; continuous variables were
analyzed through the t test and categorical variables through Pearson's
χ2 test.
Regarding the VBM analyses, group effects on regional GM volume
were investigated through whole-brain voxel-wise comparisons of the
preprocessed GM images of schizophrenia patients and controls by
using General Linear Model (GLM) Analysis of Co-variance (ANCOVA),
which always included total GM volume, scan protocol, age and gender
as nuisance variables (hereafter deﬁned as “standard covariance”).
Moreover, within-group correlationswere performed between regional
brain volumes and potential clinical moderators [psychopathology se-
verity (as assessed by PANSS total score, after excluding subjects of
one study with unavailable data (de Souza Crippa et al., 2006)), life-
time cumulative exposure to antipsychotics (as assessed by estimation
of dose-years), age of onset and duration of illness], always correcting
for the effects of the remainder potential clinicalmoderators, in addition
to the standard covariance.
It has been previously described that variations in the choice of
method for adjusting VBM-based regional GM volume indices for global
GM (total GM, TGM, i.e., the sum of GM across all voxels) may signiﬁ-
cantly affect results when making inferences about regional brain vol-
ume changes (Peelle et al., 2012). Accordingly, we conductedadditional VBM analyses using three alternative methods of covariation
for global GM, as described elsewhere (Peelle et al., 2012). First, for each
individual, we calculated TGM as the sum of GM across brain regions
using unregistered, unsmoothed MRI datasets (Peelle et al., 2012). Sub-
sequently, using the aforementioned deﬁnition of TIV, the following
VBM analyses were performed: no adjusting for TGM, with and without
total intracranial volume (TIV) being considered; global scaling, by pro-
portionally scaling each participant's GM image by the TGM from that
image (i.e., each participant's smoothed normalized GM image was di-
vided by the TGM for that participant), with andwithout TIV being con-
sidered; and local covariation, by including each participant's TGM as an
additional covariate of no interest in an ANCOVA, with and without TIV
being considered (Peelle et al., 2012). Results of such analyseswere sub-
sequently compared to those of our conventional approach in order to
verify if the neuroanatomical pattern and level of extension of regional
GM changes were substantially affected in this study according to the
method of global adjusting.
For all VBM analyses, the statistics for each voxel of the whole GM
compartment were transformed to Z scores and displayed as statistical
parametric maps (SPMs) in standard MNI space at an initial threshold
probability of Z N 3.09 (p b 0.001, uncorrected), with cluster size thresh-
old of 20 contiguous voxels (Uwatoko et al., 2015; Fusar-Poli et al.,
2012).When examining the voxelwise statistical maps, we did not con-
sider signiﬁcant ﬁndings with spatial patterns primarily around the
edges of the brain, in regions subject to artifact of partial volume and
deskulling problems (Honea et al., 2008; Gupta et al., 2014). Statistical
inference was conducted in two steps. Initially, we used a strict statisti-
cal threshold of p b 0.05, familywise error (FWE)-corrected for multiple
comparisons over the whole brain. Second, we applied small volume
correction (SVC) over the following brain regions predicted a priori to
show abnormalities in schizophrenia patients, based on recent meta-
analyses and mega-analyses of structural MRI studies on schizophrenia
(Chan et al., 2011; Bora et al., 2011; Kuhn & Gallinat, 2013): insula, dor-
solateral prefrontal cortex, superior temporal gyrus, amygdala, hippo-
campus/parahippocampal gyrus, anterior cingulate cortex, thalamus
and striatum. Such brain regions were spatially delimited by applying
normalized volumes onto the SPMs, based on the anatomical volumes
of interest that are available within the automatic anatomical labeling
SPM toolbox. Such ﬂexible statistical analyses were conducted using a
FWE-corrected threshold of p b 0.05 over the volume of the SVC-
based region, also with cluster size threshold of 20 contiguous voxels.
The SVC approach allows hypothesis-driven analyses to be performed
with correction formultiple comparisons speciﬁcally in the brain region
of interest rather than using a stricter correction for the whole brain
(Schaufelberger et al., 2007).
Finally, for the conjoined group (chronic + ﬁrst-episode), as well as
for the chronic and ﬁrst-episode groups separately, we also performed
bivariate correlation analyses (Pearson product-moment correlation,
two-tailed, p b 0.05) between global volume values (GM, WM, CSF,
TBV and TIV) and the following clinical moderators: psychopathology
severity [as assessed by PANSS total score, after excluding subjects of
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cumulative exposure to antipsychotics (as assessed by estimation of
dose-years), duration of illness, and age of onset. The effects of the
remainder clinical variables on the results of correlation analyses
between a given clinical moderator and global brain volumes were
also accounted for through partial correlation analyses (two-tailed,
p b 0.05).
In order to give a general overview of the main VBM ﬁndings of the
study, regardless of as to whether they were signiﬁcant in the whole-
brain exploratory analyses (at strict statistical signiﬁcance levels) or in
the (more ﬂexible) SVC-based analyses, all ﬁgures were constructed
based on statistical parametric maps thresholded at p b 0.001 (uncor-
rected for multiple comparisons) with a minimum cluster extent of 10
voxels, as employed elsewhere (de Wit et al., 2014).
3. Results
3.1. Demographic and clinical variables
Sociodemographic and clinical data are listed in Table 2. Patients and
controls did not differ in terms of age, but there was a signiﬁcantly
higher male predominance among schizophrenia patients in compari-
son to controls, as well as signiﬁcantly fewer years of education in
schizophrenia patients (Table 1). Chronic schizophrenia patients did
not differ from ﬁrst-episode schizophrenia patients regarding gender,
but they were signiﬁcantly older than ﬁrst episode schizophrenia pa-
tients, had higher number of years of education, a lower age of illness
onset and higher PANSS scores (Table 2). Most chronic schizophrenia
patients were on atypical antipsychotics usage, while typicals were
the most common antipsychotic class among ﬁrst episode schizophre-
nia patients, this difference being statistically signiﬁcant (Table 2). As
would be expected, chronic schizophrenia patients had higher life-
time cumulative exposure to antipsychotics.
3.2. Global volume analyses
Patients and controls did not differ in terms of total GM or WM vol-
umes, TBV and TIV (Table 3). Patients with schizophrenia had higher
CSF volumes than controls (p b 0.0001). Chronic schizophrenia patients
did not differ from ﬁrst-episode patients regarding total GM orWMvol-
umes, but CSF volumes were larger (p b 0.0001) among chronic inTable 2
Demographic and clinical characteristics of schizophrenia patients and controls.
Characteristic Schizophrenia patients
Chronic
(n = 99)
First-Episo
(n = 62)
Gender, n (%)
Male 67 (67.7) 44 (31.0)
Female 32 (32.3) 18 (69.0)
Age, years: mean ± s.d. 32.1 ± 8.0 27.7 ± 8.1
Education, years: mean ± s.d. 10.1 ± 3.1 8.6 ± 3.8
Age of onset, years: mean ± s.d. 20.2 ± 5.2 26.8 ± 8.1
Duration of illness, years: median ± s.d. 11.0 ± 8.2 0.48 ± 1.2
PANSS score, totalc: mean ± s.d. 62.6 ± 18.4c 47.8 ± 11
Antipsychotics
Typical, n (%) 15 (15.2) 43 (69.4)
Atypical, n (%) 84 (84.8) 19 (30.6)
Estimated life-time cumulative exposure, dose-yearsd: mean
± s.d.
4331.5 ±
4988.2
162.4 ±
568.5
PANSS = Positive and Negative Syndrome Scale.
a Chronic vs. ﬁrst-episode schizophrenia patients.
b Total schizophrenia patients group vs. controls; continuous variables were analyzed throu
c Data not available for one study (de Souza Crippa et al., 2006).
d Estimated life-time cumulative antipsychotics exposure expressed in dose-years after trancomparison to ﬁrst-episode patients (Table 3). However, this difference
did not remain statistically signiﬁcant when the effect of age of onset
was accounted for (Table 3).
Bivariate correlation analyses revealed signiﬁcant negative correla-
tions between life-time cumulative exposure to antipsychotics and
global volumes for both the conjoined group [(total GM, r =−0.244,
p = 0.002); (total WM, r = −0.177, p = 0.025); (TBV, r =−0.218,
p = 0.005); (TIV, r =−0.157, p = 0.047)] and for the chronic schizo-
phrenia group [(total GM, r = −0.372, p = 0.000); (total WM,
r = −0.208, p = 0.039); (TBV, r = −0.305, p = 0.002); (TIV,
r =−0.271, p = 0.007)]. When these analyses for antipsychotic expo-
sure were repeated in the chronic schizophrenia group with covariance
for disease duration, both the negative correlations with total GM
(r =−0.207, p = 0.044) and TBV (r =−0.202, p = 0.044) retained
statistical signiﬁcance, while the negative correlations with total WM
(r =−0.188, p = 0.067) and TIV (r =−0.186, p = 0.071) remained
as signiﬁcant trends. Repeated analyses for the conjoined four groups
with covariance for disease duration indicated trend signiﬁcance for
the negative correlation between total GM and antipsychotic exposure
(r =−0.143, p = 0.075).
For the conjoined group only, a signiﬁcant positive correlation was
found between CSF volumes and duration of disease (r = 0.237; p =
0.002). However, this ﬁnding lost its statistical signiﬁcance after covari-
ance for antipsychotic exposure and age of disease onset (r = 0.027,
p = 0.741).
No signiﬁcant correlations between severity of disease and global
volumes were found for any group.
3.3. Regional brain volume analyses: VBM ﬁndings of between-group
comparisons
The VBM analysis ofmain effect of diagnosis, under the strict thresh-
old of p b 0.05 (FWE-corrected) and minimum cluster extent of 20
voxels over the whole brain, revealed a pattern of cortical volume deﬁ-
cits restricted to the bilateral insulae, right striatum and left inferior
frontal gyrus when contrasting all schizophrenia patients versus
healthy controls (Fig. 1, Table 4). Small volume-corrected analyses re-
vealed reduced GM volumes in schizophrenia patients relative to con-
trols in the following additional brain regions predicted a priori to
show abnormalities: bilateral dorsolateral prefrontal cortices, bilateral
anterior cingulate cortices, bilateral thalami and left hippocampus/Statistical analysisa Controls
(n =
151)
Statistical analysisb
de Total
(n = 161)
t or χ2 df p t or χ2 df p
111 (68.9) 0.19 1 0.728 87 (57.6) 4.31a 1 0.038
50 (31.1) 64 (42.4)
30.4 ± 8.3 3.42 129.45 0.001 30.6 ±
9.0
−0.18 304.15 0.857
9.5 ± 3.5 2.47 110.17 0.01 10.7 ±
4.7
−2.57 310 0.011
22.7 ± 7.2 −6.21 159 b0.0001
5.0 ± 8.5 10.7 159 b0.0001
.9 56.1 ± 17.4c 5.48 139 b0.0001
58 (36.0) 48.6 1 b0.0001
103 (64.0)
2726.0 ±
4416.5
6.55 159 b0.0001
gh the t test and categorical variables through Pearson's χ2 test.
sformation in mg of chlorpromazine equivalents (Andreasen et al., 2010).
Table 3
Comparison of global brain volumes between schizophrenia patients and controls.
Global volumes Schizophrenia patients Statistical analysisa Controls
(n = 151)
Statistical analysisb
Chronic
(n = 99)
First-episode
(n = 62)
Total
(n = 161)
t df p t df p
Global GM volume (mm3): mean ± s.d. 667.71 ± 65.6 671.39 ± 79.2 669.13 ± 70.9 −0.32 159 0.750 661.94 ± 70.2 0.90 310 0.369
Global WM volume (mm3): mean ± s.d. 507.21 ± 55.3 520.10 ± 64.1 512.17 ± 59.0 −1.31 115.56 0.194 509.77 ± 57.7 0.36 310 0.717
Global CSF volume (mm3): mean ± s.d. 301.05 ± 36.9 275.55 ± 37.1 291.23 ± 38.9 4.25 159 b0.0001⁎ 276.79 ± 41.9 3.14 310 0.002
TBV (mm3): mean ± s.d. 1174.93 ± 117.7 1191.49 ± 141.8 1181.31 ± 127.3 −0.80 159 0.424 1171.71 ± 124.7 0.67 309 0.502
TIV (mm3): mean ± s.d. 1475.98 ± 146.6 1467.05 ± 174.0 1472.54 ± 157.3 0.35 159 0.727 1448.51 ± 158.0 1.34 308 0.180
GM= gray matter; WM=white matter; CSF = cerebrospinal ﬂuid; TBV = total brain volume; TIV = total intracranial volume.
a Chronic vs. ﬁrst-episode schizophrenia patients.
b Total schizophrenia patients group vs. controls. Continuous variables were analyzed through the t test.
⁎ This result did not remain statistically signiﬁcant when analysis was corrected for the effect of age of onset (p = 0.590).
6 U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15parahippocampal gyrus. The voxel extent of such ﬁndings and corre-
sponding Z-scores are provided in Table 4.
There were no regional GM volume deﬁcits in the ﬁrst-episode
schizophrenia sample relative to controls at FWE-corrected analyses
over the whole brain. Small volume-corrected analyses revealed re-
duced GM volumes in ﬁrst-episode schizophrenia patients in the fol-
lowing brain regions predicted a priori to show abnormalities:
bilateral insulae, right amygdala, right striatum and right hippocam-
pus/parahippocampal gyrus (Fig. 2). The voxel extent of such ﬁndingsFig. 1. Results of VBM analyses showing GM reductions occurring in the combined group of ch
slices are in coronal planes, and the right hemisphere of the brain is on the right. Statistical par
minimum cluster extent of 10 voxels. Findings are highlighted in the bilateral insulae, right stri
brain), as well as in the bilateral dorsolateral prefrontal cortices, bilateral anterior cingulate co
analyses at p b 0.05, FWE-corrected) (see Table 4 for statistical and localization details).and corresponding Z-scores are provided in Table 5. As a secondary
analysis, we carried out a voxelwise comparison of regional WM vol-
umes between FES subject and controls; this revealed no signiﬁcant
ﬁndings (at the FWE-corrected p b 0.05 level over the whole brain).
The sample of chronic schizophrenia patients presented a more ex-
tensive pattern of regional GM volume decreases relative to controls
(Fig. 3a), involving the bilateral superior, inferior and orbital frontal cor-
tices, rightmiddle frontal cortex, bilateral anterior cingulate cortices, bi-
lateral insulae, right superior and middle temporal cortices, leftronic and ﬁrst-episode schizophrenia patients (n = 161) versus controls (n = 151). Brain
ametric maps were thresholded at p b 0.001 uncorrected for multiple comparisons with a
atum and left inferior frontal gyrus (signiﬁcant at p b 0.05, FWE-corrected over the whole
rtices, bilateral thalami and left hippocampus/parahippocampal gyrus (signiﬁcant in SVC
Table 4
Regional gray matter volume reductions schizophrenia patients (chronic + ﬁrst-episode groups) relative to controls based on voxel-based morphometry analyses.
Anatomical region Number of voxels in each cluster Peak Z scorea Co-ordinates of voxel of maximal statistical signiﬁcance (MNI space)
Whole brain analysis (FWE-corrected at p b 0.05)
Left insula, left inferior frontal cortex 706 6.03 −35, 23, 1
Right insula, right striatum 104 5.09 45, 11,−6
Additional ﬁndings based on small volume-corrected analyses (FWE-corrected at p b 0.05)
Right dorsolateral prefrontal cortex 1051 4.23 21,59, 6
Left dorsolateral prefrontal cortex 643 5.96 −38, 35, 1
Right anterior cingulate cortex 165 3.66 2, 51, 13
Left anterior cingulate cortex 61 4.46 −3,53, 12
Right thalamus 179 4.03 2,−13, 6
Left thalamus 90 3.94 0,−13, 6
Left hippocampus/parahippocampal gyrus 120 3.75 −30,−30, 15
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.
7U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15postcentral gyrus, left fusiform gyrus, right thalamus, right
supramarginal gyrus, left precentral gyrus, right calcarine gyrus, leftme-
dian cingulate and paracingulate gyri, and left hippocampus/
parahippocampal gyrus (FWE-corrected analyses over the whole
brain), as shown in Table 6. Small volume-corrected analyses revealed
reducedGMvolumes in the following additional brain regions predicted
a priori to show abnormalities: left thalamus, right hippocampus/
parahippocampal gyrus, and right superior temporal gyrus. The voxelFig. 2. Results of VBM analyses showing GM reductions occurring in ﬁrst-episode schizophreni
corrected. Brain slices are in coronal planes, highlighting ﬁndings in the bilateral insulae, rig
hemisphere of the brain is on the right. Statistical parametric maps were thresholded at p b 0.0extent of such ﬁndings and corresponding Z-scores are provided in
Table 6.
In comparison to ﬁrst-episode patients, chronic schizophrenia pa-
tients showed extended GM decreases (Fig. 3b) within the bilateral su-
perior andmiddle temporal cortices, extending to left parahippocampal
gyrus and to parietal and occipital structures (bilateral angular gyri,
right supramarginal gyrus, and left inferior occipital, fusiform and lin-
gual cortices); other brain regions involved were the left inferior frontala patients (n = 62) versus controls (n= 151) identiﬁed in SVC analyses at p b 0.05, FWE-
ht amygdala, right striatum and right hippocampus/parahippocampal gyrus. The right
01 uncorrected for multiple comparisons with a minimum cluster extent of 10 voxels.
Table 5
Regional gray matter volume reductions in ﬁrst-episode schizophrenia patients relative to controls based on voxel-based morphometry analyses.
Anatomical region Number of voxels in each cluster Peak Z scorea Co-ordinates of voxel of maximal statistical signiﬁcance (MNI space)
Findings based on small volume-corrected analyses (FWE-corrected at p b 0.05)
Right striatum 49 3.67 27, 5,−11
Right hippocampus/parahippocampal gyrus 199 4.23 33,−34,−17
Right amygdala 84 4.04 27, 5,−15
Right insula 28 3.55 42, 11,−14
Left insula 29 3.64 −35, 15,−17
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.
8 U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15cortex, left superior and inferior parietal cortices, as well as left
precentral and postcentral cortices, and left insula (FWE-corrected anal-
yses over thewhole brain), as shown in Table 7. Small volume-corrected
analyses revealed reduced GM volumes in the following additional
brain regions predicted a priori to show abnormalities: right thalamus
and right amygdala. The voxel extent of such ﬁndings and correspond-
ing Z-scores are provided in Table 7.
At the p b 0.05 (FWE-corrected) statistical threshold over the whole
brain, there were no signiﬁcant ﬁndings of regional GM volume in-
creases detectable in the between-group comparisons above.
Regarding the different methods of covariation for total GM, al-
though subtle variations in the magnitude of VBM ﬁndings were
found in comparison to our standard approach, the neuroanatomical
pattern of regional changes was maintained, suggesting that results of
this study were not substantially affected by the method of global
covariation.
3.4. Effects of age of disease onset on regional volume analyses (VBM)
Whenwe repeated the above comparison between chronic andﬁrst-
episode schizophrenia patients including age of onset as a confounding
covariate, we detected a similar pattern of regional GM volume deﬁcitsFig. 3. Results of VBM analyses showing GM reductions occurring in chronic schizophrenia p
schizophrenia patients (n = 62), without covariation for age of onset (panel B). Brain slices
volumetric reductions in chronic patients; the right hemisphere of the brain is on the righ
comparisons with a minimum cluster extent of 10 voxels.in chronic patients relative to ﬁrst-episode subjects. There were exten-
sive GM decreases within the bilateral superior and middle temporal
cortices, right superior and inferior frontal cortices, left precentral and
postcentral cortices, and right occipital structures (calcarine, precuneus,
cuneus and lingual cortices); other brain regions involved were the
right thalamus, bilateral inferior parietal cortices and left superior pari-
etal cortex (p b 0.05, FWE-corrected over the whole brain) (Table 8).
Small volume-corrected analyses revealed reduced GM volumes in the
following additional brain regions predicted a priori to show abnormal-
ities: bilateral anterior cingulate cortices, left striatum, bilateral hippo-
campi/parahippocampal gyri, bilateral insulae and left thalamus. The
voxel extent of such ﬁndings and corresponding Z-scores are provided
in Table 8.
In the investigation of within-group correlations between regional
brain volumes and age of onset, we found (only in SVC-corrected anal-
yses) positive correlations involving the bilateral insulae and anterior
cingulate and dorsolateral prefrontal cortices, the right hippocampus/
parahippocampal gyrus and right superior temporal gyrus for the con-
joined four groups, after accounting for the effects of life-time cumula-
tive exposure to antipsychotics. When additionally accounting for the
effects of illness severity (in the conjoined three groups with available
PANSS total scores), the foci of positive correlation in the left anterioratients (n = 99) versus controls (n = 151) (panel A), and chronic versus ﬁrst-episode
are in axial planes in order to display the generalized ﬁndings of cortical and subcortical
t. Statistical parametric maps were thresholded at p b 0.001 uncorrected for multiple
Table 6
Regional gray matter volume reductions in chronic schizophrenia patients relative to controls based on voxel-based morphometry analyses.
Anatomical region Number of voxels in
each cluster
Peak Z
scorea
Co-ordinates of voxel of maximal statistical
signiﬁcance (MNI space)
Whole brain analysis (FWE-corrected at p b 0.05)
Bilateral hemisphere cluster, including: bilateral superior and orbital frontal cortices, right
middle frontal cortex, bilateral anterior cingulate cortices
8616 7.01 11, 47, 10
Left insula, left inferior frontal cortex 1203 6.43 −38, 35, 1
Right insula, right inferior frontal cortex 510 6.19 44, 18,−5
Right superior and middle temporal cortices 1496 5.84 53,−24,−5
Left postcentral gyrus 49 5.54 −41,−24, 43
Left fusiform gyrus 77 5.22 −36,−43,−14
Right thalamus 25 5.19 11,−10, 3
Right supramarginal gyrus 46 5.01 46,−45, 42
Left precentral gyrus 20 4.92 −48,−3, 37
Right calcarine gyrus 28 4.88 11,−63, 10
Left median cingulate and paracingulate gyrus 22 4.87 −9,−7, 48
Left hippocampus/parahippocampal gyrus 27 4.78 −27,−34,−12
Additional ﬁndings based on small volume-corrected analyses (FWE-corrected at p b 0.05)
Left thalamus 129 6.43 −9,−7, 3
Right hippocampus/parahippocampal gyrus 69 5.19 14,−6,−20
Right temporal superior gyrus 898 4.26 53,−24,−5
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.
9U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15cingulate cortex, bilateral dorsolateral prefrontal cortices, left insula,
right hippocampus/parahippocampal gyrus and right superior temporal
gyrus all remained statistically signiﬁcant. The voxel extent of these
ﬁndings and their corresponding Z-scores are provided in Table 9.3.5. Regional volume analyses: VBM ﬁndings of other signiﬁcant within-
group correlations
No signiﬁcant positive or negative correlations between other po-
tential clinical moderators (psychopathology severity, as assessed by
PANSS total score; life-time cumulative exposure to antipsychotics, as
assessed by estimation of dose-years; and duration of illness) and re-
gional brain structural changes were found for any of the patient sub-
groups when analyses were performed under the strict threshold of
p b 0.05, FWE-corrected over the whole brain.
In regard to small volume-corrected analyses, one cluster of signiﬁ-
cant negative correlation was detected in the ﬁrst-episode schizophre-
nia group between duration of disease and GM volume of the left
superior temporal gyrus (with covariance for lifetime cumulative expo-
sure to antipsychotics, overall illness severity and age of onset). TheTable 7
Regional gray matter volume reductions in chronic schizophrenia patients relative to ﬁrst-epis
Anatomical region
Whole brain analysis (FWE-corrected at p b 0.05)
Left superior temporal cortex, extending to left precentral and postcentral cortices
Right superior and middle temporal cortices, extending to right supramarginal and
angular gyri
Left middle temporal cortex, extending to left angular gyrus
Left superior and inferior parietal cortices
Left inferior temporal cortex, extending to left parahippocampal gyrus and left inferior
occipital, fusiform and lingual cortices
Left precentral cortex
Left postcentral cortex
Left inferior frontal cortex
Left insula
Additional ﬁndings based on small volume-corrected analyses (FWE-corrected at p b 0.05
Right thalamus
Right amygdala
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.voxel extent of this ﬁnding and its corresponding Z-score are provided
in Table 10.
In the conjoined four groups, small volume-corrected analyses re-
vealed several foci of signiﬁcant negative correlation between duration
of illness and GM volumes in the bilateral insulae, dorsolateral prefron-
tal cortices and hippocampi/parahippocampal gyri, after accounting for
effects of lifetime cumulative exposure to antipsychotics (Table 10).
There were additional signiﬁcant negative correlations between dura-
tion of disease and GM volumes of the bilateral anterior cingulate corti-
ces for the conjunction of the three groups with available PANSS total
scores, after accounting for effects of overall illness severity and lifetime
cumulative exposure to antipsychotics (Table 10). However, when
these negative correlations were recalculated including age of onset as
an additional confounding covariate, only a cluster in the right dorsolat-
eral prefrontal cortex retained statistical signiﬁcance, in the conjoined
three groups with available PANSS total scores (Table 10).
4. Discussion
This large cross-sectional VBM multisite mega-analysis compared
groups of schizophrenia patients (n = 161) and healthy controlsode schizophrenia patients based on voxel-based morphometry analyses.
Number of voxels in
each cluster
Peak Z
scorea
Co-ordinates of voxel of maximal statistical
signiﬁcance (MNI space)
2642 7.42 −41,−25, 6
5830 7.22 46,−46, 48
841 7.15 −44,−64, 22
665 7.06 −29,−48, 54
1508 6.79 −36,−52,−3
245 6.42 −30,−13, 45
256 6.26 −33,−31, 54
294 5.89 −29, 33,−3
108 5.12 −41, 5, 12
)
905 6.16 11,−10, 3
330 5.42 −6, 6,−3
Table 8
Regional graymatter volume reductions in chronic schizophrenia patients relative to ﬁrst-episode schizophrenia patients based on voxel-basedmorphometry analyses after correction for
the confounding effect of age of onset.
Anatomical region Number of voxels in each
cluster
Peak Z
scorea
Co-ordinates of voxel of maximal statistical signiﬁcance
(MNI space)
Whole brain analysis (FWE-corrected at p b 0.05)
Left precentral cortex 238 7.09 −48,−4, 40
Right calcarine, precuneus, cuneus and lingual cortices 1166 6.95 12,−63, 13
Right superior and middle temporal cortices 3206 6.76 45,−4,−24
Left superior temporal cortex 1228 6.45 −41,−27, 6
Right inferior parietal cortex, extending to right supramarginal and
angular gyri
552 6.27 46,−46, 48
Left middle temporal cortex 367 6.18 −44,−64, 22
Left superior and inferior parietal cortices 163 6.16 −27,−48, 54
Right thalamus 54 5.88 11,−10, 3
Left postcentral cortex 45 6.26 −44,−24, 46
Right superior frontal cortex 177 5.50 9, 39, 46
Right inferior frontal cortex 33 5.24 33, 30,−11
Additional ﬁndings based on small volume-corrected analyses (FWE-corrected at p b 0.05)
Right anterior cingulate cortex 2629 6.72 17, 44, 19
Left anterior cingulate cortex 2131 7.42 −5, 51,−2
Left striatum 323 5.22 −6, 6,−3
Right hippocampus/parahippocampal gyrus 319 6.48 42,−16,−14
Left hippocampus/parahippocampal gyrus 485 5.58 −24,−39,−8
Right insula 274 4.33 45, 18,−5
Left insula 298 3.90 −36, 0, 6
Left thalamus 181 5.70 −9,−6, 4
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.
10 U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15(n = 151) recruited in the same geographical region. While ﬁrst-
episode schizophrenia subjects displayed subtle and highly
circumscribed GM volume reductions in the brain relative to con-
trols, chronic schizophrenia patients had more signiﬁcant and wide-
spread cortical GM deﬁcits. In some brain foci, relative regional GM
volumes were directly correlated with age of disease onset. Also,
global brain volumes in schizophrenia were inversely related to the
degree of exposure to antipsychotic drugs. While the results of our
between-group comparisons provide replication to the ﬁndings of a
number of previous MRI studies of schizophrenia (Vita et al., 2012;
Ellison-Wright et al., 2008; Chan et al., 2011; Olabi et al., 2011;
Honea et al., 2005), the relevance attributed to the potentialTable 9
Results of small volume-corrected analyses (FWE-corrected at p b 0.05) showing positive corr
Anatomical region Number of voxels in each cluster Pe
All patientsb
Right dorsolateral prefrontal cortex 740 5.1
Left dorsolateral prefrontal cortex 221 4.3
Right anterior cingulate cortex 475 3.8
Left anterior cingulate cortex 174 3.6
Right insula 108 4.1
Left insula 1190 4.3
Right hippocampus/parahippocampal gyrus 286 4.0
Right superior temporal gyrus 395 4.2
Conjunction of three groups with available PANSS total scoresc
Right dorsolateral prefrontal cortex 204 4.3
Left dorsolateral prefrontal cortex 106 3.9
Left anterior cingulate cortex 103 3.5
Left insula 189 3.8
Right hippocampus/parahippocampal gyrus 252 3.7
Right superior temporal gyrus 451 4.3
First-episoded
Right superior temporal gyrus 21 3.7
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.
b After accounting for effects of lifetime cumulative exposure to antipsychotics.
c After accounting for effects of lifetime cumulative exposure to antipsychotics and overall i
d After accounting for effects of lifetime cumulative exposure to antipsychotics and durationinﬂuence of clinical moderators in our analyses is unique to date,
and allowed us to unveil some novel ﬁndings.
4.1. Gray matter volume abnormalities associated with ﬁrst-episode
schizophrenia
The comparison of ﬁrst-episode schizophrenia subjects against con-
trols identiﬁed regional GM volume deﬁcits in the former group in a
circumscribed network of brain regions including the insula,
temporolimbic structures (hippocampus/parahippocampal gyrus/
amygdala) and striatum. Volume reductions in these brain regions
have been often reported in previous VBM investigations ofelations between gray matter regional volumes and age of onset in the conjoined groups.
ak Z scorea Co-ordinates of voxel of maximal statistical signiﬁcance (MNI space)
9 42, 15, 15
0 −32, 29, 12
7 17, 42, 21
9 −2, 53, 3
6 46, 12, 3
1 −30, 29, 12
7 36,−34,−5
3 60,−48, 22
4 18, 42, 24
0 −32, 29, 12
1 −2, 54,−2
0 −30, 29, 12
7 36,−34,−3
7 60,−49, 22
8 42,−31, 4
llness severity.
of disease.
Table 10
Results of small volume-corrected analyses (FWE-corrected at p b 0.05) showing negative correlations between graymatter regional volumes and duration of disease in the conjoined and
ﬁrst-episode groups.
Anatomical region Number of voxels in each cluster Peak Z scorea Co-ordinates of voxel of maximal statistical signiﬁcance (MNI space)
All patientsb
Right insula 162 4.11 48, 8, 6
Left insula 1583 4.33 −42, 5, 10
Right dorsolateral prefrontal cortex 934 4.85 51, 15, 7
Left dorsolateral prefrontal cortex 632 4.23 −41, 6, 10
Right hippocampus/parahippocampal gyrus 226 3.86 8, 26, 21
Left hippocampus/parahippocampal gyrus 113 3.64 −27,−30,−6
Conjunction of three groups with available PANSS total scoresc
Right insula 62 3.60 48, 8, 6
Left insula 806 3.78 −29, 29,−3
Right dorsolateral prefrontal cortex 1015 4.61 18, 44, 24
Left dorsolateral prefrontal cortex 286 3.82 −30, 35,−2
Right hippocampus/parahippocampal gyrus 123 4.19 29,−19,−9
Left hippocampus/parahippocampal gyrus 190 3.77 −27,−34,−9
Right anterior cingulate cortex 23 4.07 17, 45, 21
Left anterior cingulate cortex 112 3.91 −3, 53, 1
Conjunction of three groups with available PANSS total scoresd
Right dorsolateral prefrontal cortex 258 3.94 28, 15, 52
First-episoded
Left superior temporal gyrus 108 3.82 −54,−24, 10
MNI = Montreal Neurological Institute; FWE= family-wise error.
a Z score for the voxel of maximal statistical signiﬁcance in each cluster.
b After accounting for effects of lifetime cumulative exposure to antipsychotics.
c After accounting for effects of lifetime cumulative exposure to antipsychotics and overall illness severity.
d After accounting for effects of lifetime cumulative exposure to antipsychotics, overall illness severity and age of onset.
11U.S. Torres et al. / NeuroImage: Clinical 12 (2016) 1–15schizophrenia, despite some degree of variation across separate studies
andmeta-analyses (Ellison-Wright et al., 2008; Chan et al., 2011; Honea
et al., 2005;Wright et al., 2000; Arnone et al., 2009). In our investigation,
these brain volume abnormalities were subtle, being uncovered only
when the more ﬂexible SVC approach was applied.
The involvement of the insula in the pathophysiology of schizophre-
nia has been sometimes seen simply as an “extension” of primary fron-
tal and temporal lobe pathology (Chan et al., 2011; Wylie & Tregellas,
2010). The relatively circumscribed ﬁndings of brain abnormalities in
our ﬁrst-episode schizophrenia sample, highlighting GM deﬁcits in the
insula, are not consistent with such view. Instead, the selective brain
volume deﬁcits in our ﬁrst-episode schizophrenia sample, involving
speciﬁcally the insula and temporolimbic structures, suggest that
these foci of volume abnormalities should be seen as critical brain re-
gions of neuropathology from which continuing abnormalities may
evolve to further, widespread anatomical changes in chronic schizo-
phrenia (Ellison-Wright et al., 2008; Smieskova et al., 2012).
The insula plays a critical role in emotional processing, integration of
sensory (visual and auditory) input with the limbic system, pain per-
ception, as well as being uniquely involved in interoception and neural
representations of the self (Wylie & Tregellas, 2010). Since the latter
role allows discriminating between self-generated and external infor-
mation, it has been suggested that insular dysfunction may contribute
to hallucinations, a cardinal feature of schizophrenia (Wylie &
Tregellas, 2010). The insula has extensive connections with many
areas of the cerebral cortex, and may act as an interface between the
frontal and temporal lobes. Temporolimbic structures are part of a net-
work that integrates external and internal information,mediating phys-
iological, behavioral, and psychological responses, as well as leading to
emotion-based decisions that allow for adaptation to the environment
on the basis of previous experience (White et al., 2008). In addition,
the medial temporal cortex is a critical component of the neural net-
work involved in pleasure and reward (White et al., 2008). Dysfunction
of temporolimbic structures is thought to critically contribute to the
emergence of key clinical features of schizophrenia, including both pos-
itive and negative symptoms (White et al., 2008).While none of the large multi-site cross-sectional VBM investiga-
tions of schizophrenia to date assessed ﬁrst-episode schizophrenia pa-
tients separately, a number of single-site MRI studies have evaluated
relatively large ﬁrst-episode schizophrenia samples (Meisenzahl et al.,
2008; Chua et al., 2007; Lui et al., 2009; Janssen et al., 2008; Job et al.,
2002). In the largest single-site cross-sectional VBM study of schizo-
phrenia to date, Meisenzahl et al. (Meisenzahl et al., 2008) found GM
volume reductions in several brain regions in ﬁrst-episode schizophre-
nia patients relative to healthy controls, affecting most signiﬁcantly
the perisylvian areas bilaterally, as well as the left insula, superior tem-
poral gyrus, amygdala and hippocampus. Other bilateral GM volume re-
ductions were found in the cingulate, orbitofrontal, dorsolateral and
dorsomedial prefrontal cortices, gyrus rectus, and thalami (Meisenzahl
et al., 2008). Despite the absence of signiﬁcant ﬁndings involving nota-
bly the superior temporal gyrus in our study (relative reduction in the
left superior temporal gyrus is the most signiﬁcant ﬁnding in more
than 50% of VBM studies of schizophrenia according to a meta-analysis
(Honea et al., 2005)), the results of Meisenzahl et al. (Meisenzahl et al.,
2008) are still partially in agreement with ours especially regarding the
insular and temporo-limbic GM volume abnormalities in ﬁrst-episode
schizophrenia patients. In accord with our ﬁndings, other VBM studies
that evaluated relatively large ﬁrst-episode schizophrenia samples
have also detected GM volume reductions in circumscribed regions
rather than in a widespread fashion throughout the brain (Meisenzahl
et al., 2008; Chua et al., 2007; Lui et al., 2009; Janssen et al., 2008; Job
et al., 2002).
The ﬁrst-episode schizophrenia sample included in the present
study is the same evaluated previously by our group in a VBM investiga-
tion using a less optimized (SPM 2) version of the image processing
software employed herein (Schaufelberger et al., 2007). The fact that
the same signiﬁcant results emerged in the insula and temporolimbic
structures across the two investigations suggest the robustness of the
ﬁndings implicating these two brain regions in ﬁrst-episode schizo-
phrenia. However, ﬁrst-episode schizophrenia patients in the present
investigation did not display GM volume deﬁcits in two additional
brain regions thought to be relevant to schizophrenia and which were
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(Schaufelberger et al., 2007), namely the left superior temporal gyrus
(as mentioned above) and the inferior lateral prefrontal cortex. Similar
statistical inference approacheswere applied in the two studies, and the
differences in the results obtained highlight the fact that variable VBM
ﬁndings may emerge when distinct spatial normalization and other
routines are employed for image processing (Henley et al., 2010;
Radua et al., 2014; Shen & Sterr, 2013; Callaert et al., 2014;
Bergouignan et al., 2009; Tahmasebi et al., 2009). Also, a larger control
group was employed in the current investigation compared to our pre-
vious publication, including a proportion of healthy individuals that
were not recruited in the same neighborhood of the schizophrenia pa-
tients, as in our previous study (Schaufelberger et al., 2007). Neverthe-
less, it should be noted that the current SPM8-based analyses did allow
detection of a signiﬁcant ﬁnding involving the left superior temporal
gyrus in the ﬁrst-episode schizophrenia group, consisting of an inverse
correlation betweenGMvolumeof this regions and disease duration be-
fore MRI scanning.
4.2. Greater structural brain volume deﬁcits in chronic schizophrenia
patients
Whether schizophrenia is characterized or not by progressive struc-
tural brain changes is of importance to further clarify the pathophysiol-
ogy of the disorder. The neurodevelopmental hypothesis proposes that
schizophrenia is a consequence of a disruption in early brain develop-
ment, and that an interaction between early brain insults and later envi-
ronmental factors would trigger the emergence of psychotic behavior
and other overt symptoms of schizophrenia from early adulthood on-
wards (Weinberger, 1987; Murray, 1994). Evidence associating prena-
tal and perinatal complications with the diagnosis of schizophrenia
later in life, absence of gliosis in the brains of schizophrenia patients
as evaluated in postmortem studies, and detection of structural brain
changes by MRI before illness onset, have all been taken to support
the neurodevelopmental model for schizophrenia (Fusar-Poli et al.,
2011; Smieskova et al., 2010; Jones et al., 1998; Falkai et al., 1999). How-
ever, the heterogeneous and sometimes deteriorating clinical course of
schizophrenia suggests that neurodegenerative processes may also
occur in schizophrenia, mainly in early stages after the onset of the ill-
ness (DeLisi, 2008; Lieberman et al., 1997). Evidence supporting the
neurodegenerative hypothesis of schizophrenia includes ﬁndings from
longitudinal neuroimaging studies showing progressive structural
brain changes, such as cortical GM volume reductions and ventricular
enlargement, in schizophrenia patients (Borgwardt et al., 2009). The hy-
pothesis of neurodegeneration, however, has been controversial be-
cause the ﬁndings of different neuroimaging studies have at times
been inconsistent, with some authors ﬁnding no brain volume changes
over time (Whitworth et al., 2005) or even a reversal of GM decline in
longitudinal MRI evaluations (Keshavan et al., 1998). Differences in
image analysis techniques, duration of follow-up intervals and clinical
characteristics of the schizophrenia samples recruited for each study
may help to explain such heterogeneity in results of longitudinal MRI
studies.
In concordance with our initial hypothesis, we detected a more
widespread pattern of structural GM changes in chronic than ﬁrst-epi-
sode schizophrenia patients in comparison to controls. Such pattern of
results might be taken to support the notion that brain changes associ-
ated with the diagnosis of schizophrenia progress over the course of the
illness. Our ﬁndings of extensive GMdeﬁcits among chronic schizophre-
nia patients are consistent with the results of previous meta-analyses
that performed indirect comparisons between groups of ﬁrst-episode
and chronic schizophrenia patients (Vita et al., 2012; Ellison-Wright et
al., 2008; Chan et al., 2011; Olabi et al., 2011; Honea et al., 2005). Our
ﬁndings are also in agreement with the results of the previous VBM-
based mega-analysis by Meisenzahl et al. (Meisenzahl et al., 2008)
which applied a similar cross-sectional design to analyze MRI datafrom schizophrenia patients and controls. Among chronic schizophrenia
patients,Meisenzahl et al. (Meisenzahl et al., 2008) found extensive GM
deﬁcits involving the insula, dorsolateral and ventrolateral prefrontal
cortices, anterior cingulate cortex, temporolimbic region (including
the hippocampus, amygdala and parahippocampal gyrus) and superior
temporal gyrus, as well as the caudate nuclei bilaterally. Interestingly,
our results demonstrate a pattern of volume abnormalities in a very
similar neuroanatomical circuitry, includingGMvolumedeﬁcits in insu-
lar, frontal and temporolimbic brain regions in chronic schizophrenia.
Such a pattern of fronto-temporolimbic volume changes in chronic
schizophrenia is also in accordancewith themeta-analytic seminalﬁnd-
ings by Ellison-Wright et al. (Ellison-Wright et al., 2008). Finally, regard-
ing the results of previous multisite mega-analyses, Segall et al. (Segall
et al., 2009) evaluated 503 subjects (237 chronic patients diagnosed
with schizophrenia, schizoaffective or schizophreniform disorder and
266 controls) and reported a pattern of GM reductions in the group of
patients relative to controls that was most pronounced in the inferior
frontal gyrus, insula, parahippocampal gyrus, superior temporal gyrus,
and rectal gyrus. Such abnormalities were even more widespread in a
further, larger mega-analysis evaluating chronic schizophrenia patients
by Gupta et al. (Gupta et al., 2014) (1720 subjects; 784 schizophrenia
patients and 936 controls), which revealed structural alterations in re-
gions that covered most of the brain in a single cluster (i.e., whole-
brain volumetric reduction in schizophrenia).
The convergent ﬁnding of large fronto-temporolimbic GM volumet-
ric deﬁcits in our analyses and the aforementioned studies of chronic
schizophrenia subjects (Meisenzahl et al., 2008; Gupta et al., 2014;
Segall et al., 2009) is consistent with the relevance attributed to these
brain regions in the pathophysiology of schizophrenia (Vita et al.,
2012). Fronto-temporal regions have been implicated in a range of cog-
nitive processes affected in schizophrenia, including attention, lan-
guage, working memory and other aspects of executive functioning, as
well aswith the expression of different clinical features of schizophrenia
(Cobia et al., 2012). The relevance of GM volume deﬁcits in chronic
schizophrenia affecting frontal brain regions is also highlighted in our
study by the ﬁnding of a signiﬁcant negative correlation between illness
duration andGMdeﬁcits in schizophrenia patients in the right dorsolat-
eral prefrontal cortex, which remained signiﬁcant after accounting for
the effects of age of disease onset and degree of antipsychotic exposure.
One issue when interpreting results of widespread brain volume
deﬁcits in samples of chronic schizophrenia patients is the extent to
which such ﬁndingsmay vary speciﬁcally as a function of greater illness
severity, rather than reﬂecting the continuation of schizophrenia over
time. Cases of schizophrenia that aremore severe could conceivably dis-
play, at the time of disease onset, greater brain abnormalities that may
not necessarily progress over time (Zipursky et al., 2013). In our study,
a difference in the recruitment strategy between ﬁrst-episode and
chronic schizophrenia patients likely favoured the inclusion of more se-
vere cases of schizophrenia in the latter group. For the recruitment of
the ﬁrst-episode group, a team of researchers actively surveilled local
mental health services in a predeﬁned catchment area (Schaufelberger
et al., 2007), thus allowing the recruitment of cases of varying degrees
of severity in the schizophrenia spectrum; a follow-up investigation
after a mean of 1.5 years actually revealed remission of symptoms in a
signiﬁcant minority of schizophrenia cases (Schaufelberger et al.,
2011). Conversely, our chronic schizophrenia patients were selected
from tertiary hospital settings, thus potentially biasing the recruitment
towards more severe cases, some of which with a history of recurrent
hospital admissions. It is therefore likely that the ﬁnding of more wide-
spread cortical GM volume deﬁcits in our chronic schizophrenia group
was inﬂuenced by the inclusion of more severe cases in that speciﬁc
group, rather than simply reﬂecting the overall effects of greater illness
duration in the chronic schizophrenia group. This possibility is rein-
forced by the fact that the chronic schizophrenia group in our study
had substantially earlier disease onset relative to the ﬁrst-episode
group, since it is well known that earlier age of onset of schizophrenia
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Clemmensen et al., 2012). Accordingly, our voxelwise search for corre-
lations between regional GMvolumes and clinicalmoderators indicated
the presence of signiﬁcant positive correlations between age of disease
onset and GM volumes in several of the brain regions where chronic
schizophrenia patients displayed reduced GM volumes in comparison
to both ﬁrst-episode patients and healthy controls.
The notion that greater GM volume deﬁcits in schizophrenia de-
pends on clinical severity rather than simply reﬂecting illness chronicity
is also supported by a number of recent longitudinal MRI studies of
schizophrenia which have suggested that signiﬁcant progression of
brain volume deﬁcits in schizophrenia over time relative to controls
may be present predominantly in a subset of patients withmore severe
illness andworse prognosis (Vita et al., 2012; vanHaren et al., 2011). In-
cluded among those MRI investigations is a study in which a subset of
the present ﬁrst-episode schizophrenia sample was re-scanned after a
mean of 5 years, with ﬁndings of GM decrements over time being de-
tected in selected cortical regions only in schizophrenia subjects with
a more severe, non-remitting course of illness (Rosa et al., 2015). How-
ever, in this study, we did not ﬁnd any signiﬁcant correlations between
regional brain volumes and overall illness severity, suggesting that such
moderatormay be part of a complex interaction of factorswith different
weights on the brain structural abnormalities detectable in chronic
schizophrenia.
4.3. Relationship between brain volume deﬁcits and antipsychotic use
The continued use of antipsychotic medication has been previously
highlighted as a potentially contributing factor inﬂuencing on the pro-
gression of GM volume deﬁcits in chronic schizophrenia patients
(Fusar-Poli et al., 2013; Torres et al., 2013; Veijola et al., 2014; Vita et
al., 2015; Guo et al., 2015). This possibility has been supported by stud-
ies in animals showing structural brain changes in association with
chronic antipsychotic administration (Dorph-Petersen et al., 2005;
Konopaske et al., 2007; Konopaske et al., 2008). Recently, a meta-analy-
sis of longitudinal MRI studies found progressive GM decreases among
schizophrenia patients that were inversely correlated with cumulative
exposure to antipsychotics, and such relationship could not be
accounted for by illness duration or severity (Fusar-Poli et al., 2013).
One othermeta-analysis of longitudinalMRI studies focusing on typical-
ity of antipsychotics found a signiﬁcant correlation between cumulative
antipsychotic exposure and progressive GM deﬁcits in schizophrenia,
although such changes were less prominent among patients treated
with second-generation antipsychotics (Vita et al., 2015).
In contrastwith the previousmultisite VBM-basedmega-analyses of
schizophrenia (Gupta et al., 2014; Segall et al., 2009), we were able to
carefully quantify the lifetime cumulative dosage of antipsychotics in
our schizophrenia patients. With that strategy, we did ﬁnd signiﬁcant
negative correlations between life-time cumulative exposure to anti-
psychotics and global brain volumes in the schizophrenia group, after
accounting for the effects duration of illness. Such results are consistent
with ﬁndings of previous animal studies which have demonstrated dif-
fuse reductions in brain volume and weight in macaque monkeys ex-
posed to olanzapine or haloperidol compared to placebo (Dorph-
Petersen et al., 2005) as well as meta-analytic data from longitudinal
MRI studies in schizophrenia patients showing that global GM volume
decrements over time are related to cumulative exposure to antipsy-
chotic treatments (Fusar-Poli et al., 2013). Thus our results gives sup-
port to the hypothesis that the continued use of antipsychotics may
signiﬁcantly inﬂuence the progression of neuroanatomical deﬁcits in
schizophrenia (Zipursky et al., 2013).
It should be noted that we found no signiﬁcant correlations between
indices of antipsychotic exposure and relative regional GM volume def-
icits in schizophrenia patients. Therefore, we cannot attribute the ﬁnd-
ings of regional GM volume deﬁcits located in fronto-temporal
cortices in chronic schizophrenia subjects to the continued exposureto antipsychotic drugs (Fusar-Poli et al., 2013; Torres et al., 2013;
Veijola et al., 2014; Vita et al., 2015; Guo et al., 2015). In light of the re-
sults of themeta-analysis byVita et al. (Vita et al., 2015), the preponder-
ance of patients using second-generation antipsychotics in our chronic
sample (64% vs. 36%) may have contributed to the absence of ﬁndings
relating medication use to relative GM abnormalities affecting fronto-
temporal regions in the present study.
The combined ﬁndings of our study regarding medication use, with
effects on global rather than regional brain volumes in schizophrenia,
are pioneer for a cross-sectional VBM mega-analysis. Nevertheless,
this remains an open question, yet to be scrutinized in further mega-
analyses of cross-sectional and longitudinal MRI studies.
4.4. Strengths and limitations
Our study has several strengths.With ourmultisite study design, we
gained statistical power by pooling together large samples of schizo-
phrenia patients and demographically matched controls. The potential-
ly confounding effects of heterogeneous image acquisition protocols
were addressed by using a uniform image preprocessing pipeline and
by entering site/scanning protocol in the GLM used for the statistical
analysis. Previous technical reports have demonstrated that results of
analyses performed by pooling together MRI datasets from multiple
centers are not substantially confounded by scanner differences when
such methodological approach is applied (Stonnington et al., 2008;
Pardoe et al., 2008). Similar strategies have been employed in two pre-
vious mega-analyses of MRI datasets from schizophrenia patients and
controls (Gupta et al., 2014; Segall et al., 2009). Also, we conducted re-
peated analyses of regional GM volumes with covariance for different
indices of global brain volumes, which varied in regard to the involve-
ment of the distinct tissue compartments in the brain; the consistency
of the results obtained in all analyses ensured that our regional GM vol-
ume ﬁndings were not inﬂuenced by global volume differences variably
affecting different brain compartments in schizophrenia patients and
controls. Finally, in contrast to the other multisite VBM studies of
schizophrenia published to date, which gathered subjects from a wide
range of geographical areas across USA and Europe (Gupta et al.,
2014; Segall et al., 2009), our participants were drawn from only two
urban centers separated by approximately 195 miles in the state of
São Paulo, Brazil. Thus we potentially reduced variability of brain mea-
surements related to geographical and environmental differences
across separate MRI scanning sites (Kirkbride et al., 2012).
On the other hand, we acknowledge that our study is not without
limitations. First, while attempting to assess the inﬂuence of various
clinical moderators on GM volumes, we were unable to address the
role of some other potentially relevant confounders evaluated in the
previous neuroimaging literature on schizophrenia, such as changes in
patterns of antipsychotic usage, treatment adherence, duration of un-
treated psychosis and substance abuse (van Haren et al., 2008). Also,
we cannot rule out in our study the inﬂuence of other confounders
that vary systematically between groups of patients with psychiatric
disorders and controls, such as smoking habits, other cardiovascular
risk factors and metabolic comorbidities (Weinberger & Radulescu,
2015). Finally, it could be argued that the 1.5 T magnetic ﬁeld strength
of all MRI scanners that provided data for this study could limit the re-
sults of our analyses. Although increasing the magnetic ﬁeld strength
from 1.5 to 3 T theoretically would roughly double the signal-to-noise
ratio, with consequent higher contrast-to-noise to better differentiate
GM and other tissues (Ho et al., 2010), conversely 3 T magnetic reso-
nance images often have an increased level of artifact (Ho et al., 2010;
Bernstein et al., 2006). The latter aspect potentially affects the accuracy
of automated algorithms that classify tissue into gray and white matter
components (Ho et al., 2010; Sled et al., 1998) aswell as leading to local
spatial distortion and artifactual local variations in image intensity (Ho
et al., 2010). Moreover, recent VBM (Marchewka et al., 2014; Tardif et
al., 2010) and other structural MRI studies that used other image
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an impact of ﬁeld strength on the results of analyses investigating brain
abnormalities in patients with brain disorders. Finally, recent VBMmul-
tisite mega-analyses in schizophrenia were carried out using data ac-
quired with different scanners at 1.5 T, 3 T and 4 T and this factor has
not been found to limit results and conclusions (i.e., in a subset of sub-
jects scanned in two separate sites using different acquisition protocols,
there was no signiﬁcant interaction between the effects of scanner and
group) (Segall et al., 2009).
4.5. Conclusion
In conclusion, the results of this multi-site VBM study of schizophre-
nia carried out in Brazil reinforce the notion that structural brain chang-
es associated with the diagnosis of schizophrenia are more widespread
in chronic schizophrenia compared to ﬁrst-episode patients, mainly af-
fecting fronto-temporal regions and the insula. Our VBM ﬁndings of sig-
niﬁcant correlations also suggest that relative GM volume deﬁcits may
be greater in (presumably more severe) cases with earlier age of
onset, aswell as varying as a function of illness duration in speciﬁc fron-
tal brain regions. Finally, our results highlight the potentially complex
effects of the continued use of antipsychotic drugs on structural brain
abnormalities in schizophrenia, as we found that cumulative doses of
antipsychotics affected brain volumes globally rather than selectively
on frontal-temporal regions.
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